Clinical trial

MethMax Trial: MAXimising the METHotrexate Therapy Potential in Patients With Active Rheumatoid Arthritis

NCT06649136

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-08-12

PhasePHASE4

Study timeline

Study start (actual)2024-08-12Date precision: day

Registry last updated2026-10-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

MethotrexateDRUG · verified · RxNorm: methotrexate

Sponsors & collaborators

Medical University of Viennalead sponsor

Leiden University Medical Centercollaborator

Queen Mary University of Londoncollaborator

Carol Davila University of Medicine and Pharmacy, Clinical Centre for Rheumatic Diseases, Bucharestcollaborator

Humanitas Mirasole S.p.A. - Instituto Clinico Humanitas (ICH), Rozzano (Milan)collaborator

Region Stockholm, Solnacollaborator

Diakonhjemmet Hospital AS (DH), Oslocollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06649136 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.